Exane Derivatives’s PG&E PCG Stock Holding History

Exane Derivatives’s Portfolio PCG Stock Details PCG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$30	Sell	3 -3,576	-100%	-$42.1K	﹤0.01%	752
2022 Q1	$42.7K	Sell	3,579 -1,687	-32%	-$19.9K	0.01%	586
2021 Q4	$63.9K	Buy	5,266 +611	+13%	+$7.16K	0.02%	475
2021 Q3	$44.7K	Hold	4,655	–	–	0.01%	627
2021 Q2	$46.5K	Sell	4,655 -469	-9%	-$5.03K	0.01%	655
2021 Q1	$60K	Buy	5,124 +219	+4%	+$2.54K	0.02%	500
2020 Q4	$61.1K	Buy	4,905 +1,733	+55%	+$19.6K	0.02%	444
2020 Q3	$29.8K	Buy	3,172 +1,677	+112%	+$15.5K	0.01%	402
2020 Q2	$13.3K	Sell	1,495 -5,312	-78%	-$57.9K	﹤0.01%	407
2020 Q1	$61.2K	Hold	6,807	–	–	0.02%	341
2019 Q4	$86.8K	Buy	6,807 +1,215	+22%	+$10.4K	0.02%	333
2019 Q3	$55.9K	Hold	5,592	–	–	0.01%	366
2019 Q2	$128K	Buy	5,592 +18	+0.3%	+$362	0.02%	301
2019 Q1	$99.2K	Sell	5,574 -98	-2%	-$1.58K	0.02%	294
2018 Q4	$135K	Hold	5,672	–	–	0.02%	289
2018 Q3	$260K	Sell	5,672 -22	-0.4%	-$980	0.05%	227
2018 Q2	$243K	Sell	5,694 -150	-3%	-$6.5K	0.04%	246
2018 Q1	$253K	Buy	5,844 +787	+16%	+$33.4K	0.05%	227
2017 Q4	$227K	Sell	5,057 -748	-13%	-$41.9K	0.04%	231
2017 Q3	$395K	Sell	5,805 -1,911	-25%	-$131K	0.07%	149
2017 Q2	$512K	Sell	7,716 -1,340	-15%	-$90.2K	0.11%	135
2017 Q1	$601K	Buy	9,056 +752	+9%	+$47.9K	0.14%	122
2016 Q4	$505K	Sell	8,304 -2,530	-23%	-$152K	0.1%	153
2016 Q3	$663K	Sell	10,834 -900	-8%	-$57.1K	0.1%	139
2016 Q2	$750K	Sell	11,734 -349	-3%	-$20.9K	0.12%	102
2016 Q1	$722K	Buy	12,083 +1,522	+14%	+$84.8K	0.1%	110
2015 Q4	$562K	Buy	10,561 +449	+4%	+$23.9K	0.08%	109
2015 Q3	$534K	Sell	10,112 -1,053	-9%	-$53.8K	0.07%	123
2015 Q2	$548K	Sell	11,165 -1,125	-9%	-$58.5K	0.06%	137
2015 Q1	$652K	Sell	12,290 -3,711	-23%	-$205K	0.07%	119
2014 Q4	$852K	Buy	+16,001	New	+$793K	0.12%	107

Other funds holding PCG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Exane Derivatives's PCG Position: Q2 2022 in Review

Exane Derivatives reduced its PG&E (PCG) stake by 100% in Q2 2022, selling an estimated $42.1K and leaving 3 shares worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #752.

Exane Derivatives first reported a position in PCG in Q4 2014 and has held it in 31 quarters since. The position peaked at $852K in Q4 2014. 444 funds tracked by Wall St. Rank hold PCG as of Q2 2022.

Exane Derivatives held 3 shares of PG&E worth $30 as of Q2 2022.
Exane Derivatives sold 3,576 PG&E shares in Q2 2022, an estimated $42.1K.
PG&E made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #752 holding.
Exane Derivatives first reported a position in PG&E in Q4 2014 and has held it in 31 quarters since.
Exane Derivatives's PG&E position peaked at $852K in Q4 2014.
444 funds tracked by Wall St. Rank held PG&E as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.